Decreased expression of MDR1 in PEG-conjugated hemoglobin solution combined cisplatin treatment in a tumor xenograft model

References

• Ansiaux R, Baudelet C, Jordan BF, Beghein N, Sonveaux P, De Wever J, Martinive P, Gregoire V, Feron O, Gallez B. 2005. Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. Clin Cancer Res. 11(2):743–750.
   PubMedGoogle Scholar
• Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC, Colgan SP. 2002. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 62(12):3387–3394.
   PubMedGoogle Scholar
• Dai M, Yu M, Han J, Li H, Cui P, Liu Q, Xiu R. 2008. PEG-conjugated hemoglobin combination with cisplatin enforced the antiangiogeic effect in a cervical tumor xenograft model. Artif Cells Blood Substit Immobil Biotechnol. 36(6):487–497.
   PubMedGoogle Scholar
• Ding Z, Yang L, Xie X, Xie F, Pan F, Li J, He J, Liang H. 2010. Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells. J Cancer Res Clin Oncol. 136(11):1697–707.
   PubMedGoogle Scholar
• George I, Yi GH, Schulman AR, Morrow BT, Cheng Y, Gu A, Zhang G, Oz MC, Burkhoff D, Wang J. 2006. A polymerized bovine hemoglobin oxygen carrier preserves regional myocardial function and reduces infarct size after acute myocardial ischemia. Am J Physiol Heart Circ Physiol. 291(3):H1126–H1137.
   Google Scholar
• Han HK, Han CY, Cheon EP, Lee J, Kang KW. 2007. Role of hypoxia-inducible factor-alpha in hepatitis-B-virus X protein-mediated MDR1 activation. Biochem Biophys Res Commun. 357(2):567–573.
   PubMedGoogle Scholar
• Han J, Yu M, Dai M, Cui P, Li H, Zhang J, Liu Q, Xiu R. 2008. Effect of artificial oxygen carrier with chemotherapy on tumor hypoxia and neovascularization. Artif Cells Blood Substit Immobil Biotechnol. 36(5):431–438.
   PubMedGoogle Scholar
• Ji Z, Long H, Hu Y, Qiu X, Chen X, Li Z, Fan D, Ma B, Fan Q. 2010. Expression of MDR1, HIF-1alpha and MRP1 in sacral chordoma and chordoma cell line CM-319. J Exp Clin Cancer Res. 29:158.
   PubMedGoogle Scholar
• Kaanders JH, Bussink J, van der Kogel AJ. 2004. Clinical studies of hypoxia modification in radiotherapy. Semin Radiat Oncol. 14(3):233–240.
   PubMedGoogle Scholar
• Lemus-Varela ML, Flores-Soto ME, Cervantes-Munguia R, Torres-Mendoza BM, Gudino-Cabrera G, Chaparro-Huerta V, Ortuno-Sahagun D, Beas-Zarate C. 2010. Expression of HIF-1 alpha, VEGF and EPO in peripheral blood from patients with two cardiac abnormalities associated with hypoxia. Clin Biochem. 43(3):234–239.
   PubMedGoogle Scholar
• Magnon C, Opolon P, Ricard M, Connault E, Ardouin P, Galaup A, Metivier D, Bidart JM, Germain S, Perricaudet M, Schlumberger M. 2007. Radiation and inhibition of angiogenesis by canstatin synergize to induce HIF-1alpha-mediated tumor apoptotic switch. J Clin Invest. 117(7):1844–1855.
   PubMedGoogle Scholar
• May D, Itin A, Gal O, Kalinski H, Feinstein E, Keshet E. 2005. Ero1-L alpha plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer. Oncogene. 24(6):1011–1020.
   PubMedGoogle Scholar
• Nishi H, Nakada T, Hokamura M, Osakabe Y, Itokazu O, Huang LE, Isaka K. 2004. Hypoxia-inducible factor-1 transactivates transforming growth factor-beta3 in trophoblast. Endocrinology. 145(9):4113–4118.
   PubMedGoogle Scholar
• Norrby K. 2006. In vivo models of angiogenesis. J Cell Mol Med. 10(3):588–612.
   PubMedGoogle Scholar
• Nozue M, Lee I, Manning JM, Manning LR, Jain RK. 1996. Oxygenation in tumors by modified hemoglobins. J Surg Oncol. 62(2):109–114.
   PubMedGoogle Scholar
• Ohishi Y, Oda Y, Uchiumi T, Kobayashi H, Hirakawa T, Miyamoto S, Kinukawa N, Nakano H, Kuwano M, Tsuneyoshi M. 2002. ATP-binding cassette superfamily transporter gene expression in human primary ovarian carcinoma. Clin Cancer Res. 8(12):3767–3775.
   PubMedGoogle Scholar
• Pyr dit Ruys S, Delaive E, Demazy C, Dieu M, Raes M, Michiels C. 2009. Identification of DH IC-2 as a HIF-1 independent protein involved in the adaptive response to hypoxia in tumor cells: A putative role in metastasis. Biochim Biophys Acta. 1793(11):1676–1690.
   PubMedGoogle Scholar
• Robinson MF, Dupuis NP, Kusumoto T, Liu F, Menon K, Teicher BA. 1995. Increased tumor oxygenation and radiation sensitivity in two rat tumors by a hemoglobin-based, oxygen-carrying preparation. Artif Cells Blood Substit Immobil Biotechnol. 23(3):431–438.
   PubMedGoogle Scholar
• Schnitzer SE, Schmid T, Zhou J, Brune B. 2006. Hypoxia and HIF-1alpha protect A549 cells from drug-induced apoptosis. Cell Death Differ. 13(9):1611–1613.
   PubMedGoogle Scholar
• Seruga B, Ocana A, Tannock IF. 2011. Drug resistance in metastatic castration-resistant prostate cancer. Nat Rev Clin Oncol. 8(1):12–23.
   PubMedGoogle Scholar
• Singh A, Settleman J. 2010. EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer. Oncogene. 29(34):4741–4751.
   PubMed Web of Science ®Google Scholar
• Sullivan R, Pare GC, Frederiksen LJ, Semenza GL, Graham CH. 2008. Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity. Mol Cancer Ther. 7(7):1961–1973.
   PubMedGoogle Scholar
• Tanaka M, Okazaki T, Suzuki H, Abbruzzese JL, Li D. 2011. Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome. Cancer. 117(4):744–751.
   PubMedGoogle Scholar
• Teicher BA, Holden SA, Dupuis NP, Kusomoto T, Liu M, Liu F, Menon K. 1994. Oxygenation of the rat 9L gliosarcoma and the rat 13672 mammary carcinoma with various doses of a hemoglobin solution. Artif Cells Blood Substit Immobil Biotechnol. 22(3):827–833.
   PubMedGoogle Scholar
• Weidner N. 1995. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat. 36(2):169–180.
   PubMedGoogle Scholar
• Yamamoto M, Izumi Y, Horinouchi H, Teramura Y, Sakai H, Kohno M, Watanabe M, Kawamura M, Adachi T, Ikeda E, Takeoka S, Tsuchida E, Kobayashi K. 2009. Systemic administration of hemoglobin vesicle elevates tumor tissue oxygen tension and modifies tumor response to irradiation. J Surg Res. 151(1):48–54.
   PubMedGoogle Scholar
• Yu M, Han J, Dai M, Cui P, Li H, Liu Q, Xiu R. 2008. Influence of PEG-conjugated hemoglobin on tumor oxygenation and response to chemotherapy. Artif Cells Blood Substit Immobil Biotechnol. 36(6):551–561.
   PubMedGoogle Scholar
• Zetter BR. 1998. Angiogenesis and tumor metastasis. Annu Rev Med. 49:407–424.
   PubMed Web of Science ®Google Scholar
• Zhang C, Lu L, Li Y, Wang X, Zhou J, Liu Y, Fu P, Gallicchio MA, Bach LA, Duan C. 2011. IGF binding protein-6 expression in vascular endothelial cells is induced by hypoxia and plays a negative role in tumor angiogenesis. Int J Cancer. available online. doi: 10.1002/ijc.26201.
   Google Scholar
• Zhao Q, Du J, Gu H, Teng X, Zhang Q, Qin H, Liu N. 2007. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells. Pancreas. 34(2):242–247.
   PubMedGoogle Scholar